| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece
Address correspondence and reprint requests to Georgia Kostopanagiotou, MD, PhD, 2 Florinis Str, Vrilissia, Athens, GR-15 235, Greece. Address e-mail to narkado{at}otenet.gr
| Abstract |
|---|
|
|
|---|
Implications: We report a case of accidental epidural injection of vecuronium in a female patient who underwent hemorrhoidectomy using epidural anesthesia. Because epidural injection of muscle relaxants may have serious side effects, immediate establishment of airway protection, monitoring of muscle relaxation, and follow-up for clinical signs of neurotoxicity are recommended.
| Introduction |
|---|
|
|
|---|
| Case Report |
|---|
|
|
|---|
Because of the patients psychological intolerance to the operative environment we proceeded to general anesthesia, although epidural anesthesia had been successfully initiated. Anesthesia was induced with propofol (1.5 mg/kg), thiopental (3.5 mg/kg), and maintained with 66% nitrous oxide in oxygen. Succinylcholine (1.5 mg/kg) was administered for neuromuscular blockade, and the airway was secured with a size 4 laryngeal mask. The patient had had an uneventful previous surgery using succinylcholine. Standard monitoring equipment was used. Five minutes after the induction of anesthesia, 10 mL of vecuronium was mistaken for ropivacaine and was accidentally injected as a slow bolus through the epidural catheter. Neuromuscular blockade was monitored by train-of-four (TOF) ulnar nerve stimulation. No volatile anesthetics were used. To accelerate systemic absorption of vecuronium, 10 mL of NS 0.9% solution was injected from the epidural catheter. When the accident was recorded, the maximum neuromuscular blockade was 100%. After epidural vecuronium injection, recovery of the TOF response to a ratio of 10%, 25%, 50%, and 70% occurred at 80, 90, 100, and 105 min, respectively. When TOF response reached 70%, the residual neuromuscular blockade was reversed with 0.04 mg/kg neostigmine and 0.02 mg/kg atropine IV. Five minutes after the reversal, the patient was able to sustain head lift > 3 s, had adequate spontaneous ventilation, demonstrated adequate coordinated respiratory effort, and was fully awake, oriented, and able to follow commands appropriately. Within 2 h from the time of the vecuronium injection, the patient had no evidence of muscle weakness, back pain, headache, discomfort, fever, or other metabolic, mental, or hemodynamic alterations. A thorough examination and a specialist neurological assessment revealed no sign of even sensory or motor blockade.
The patient was discharged from the postanesthesia care unit on the sixth postoperative hour and from the hospital on the second postoperative day. Follow-up for clinical signs of neurotoxicity was negative at 2 mo.
| Discussion |
|---|
|
|
|---|
Few data exist regarding the time course of IM or sites other than IV administered relaxants. After rocuronium is administered into the deltoid muscle, plasma concentrations peak at 13 min, and approximately 80% of the drug is absorbed systemically (3,4).
Neuromuscular blocking drugs cause excitement and seizures when introduced into the central nervous system (57). Acute intrathecal administration of these drugs leads to dose-dependent central nervous system effects in the rat (5). Comparisons of intraventricular seizure threshold doses revealed that pancuronium and atracurium are approximately 12 and 28 times, respectively, more potent than vecuronium in eliciting seizures. At 1/100 of seizure dose, decreased locomotor activity and piloerection occurred. At 1/10 to 1/5 of seizure dose, agitation, shivering, splayed limbs, and whole-body shaking resulted (5). These effects may be the result of accumulation of cytosolic calcium caused by sustained activation of acetylcholine receptor ion channels (6,8,9). At present, we have no information on the kinetics of disposition of the neuromuscular blocking drugs after their intraventricular administration. Data that would permit a comparison of the relative sensitivity of the rodent brain to neuromuscular relaxants with that of the human brain are not available.
Because no clinical or experimental data exist about interactions between vecuronium and other drugs injected epidurally, no other drugs should be given at this site. Although we injected saline into the epidural space to accelerate systemic absorption of vecuronium ("volume effect"), there is not sufficient evidence in the literature that this maneuver is effective (10). Volatile anesthetics may interfere with vecuronium-induced neuromuscular blockade; however, there is no convincing argument to avoid vapor-based anesthesia in the presence of vecuronium (1113).
In conclusion, to prevent the serious side effects of accidental injection of vecuronium through an epidural catheter, immediate care should include establishment of airway protection, monitoring of muscle relaxation, avoidance of medications that may interfere with neuromuscular blockade or antagonism, and follow-up for clinical signs of neurotoxicity.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Anta, C. Athanasios, M. Panorea, and V. Kyriaki Accidental epidural administration of succinylcholine. Anesth. Analg., April 1, 2006; 102(4): 1139 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Krataijan and N. Laeni Accidental Epidural Injection of Pancuronium Anesth. Analg., May 1, 2005; 100(5): 1546 - 1547. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|